A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Clinical trial NCT04562090 · COMPLETED

Trial details

NCT number: NCT04562090
Sponsor: Astellas Pharma China, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Urge Incontinence Overactive Bladder (OAB)

Start date: 2021-01-06
Primary completion: 2022-03-17
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.